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Purpose/Objective: The purpose was to design and implement a 
comprehensive computerised calculation program to execute 
radiation-shielding evaluations for radiotherapy. The program 
addresses both individual and collective contributing factors that are 
intrinsic to shielding calculations e.g. building construction, treatment 
equipment and delivery techniques, workload and occupancy. It 
incorporates modern and emerging novel treatment delivery 
techniques and the resulting overall effects on radiation protection 
required. The secondary aim was to verify the shielding program by 
applying it to existing bunkers where measurements of photon and 
neutron doserate were made and to identify its advantages for 
modelling future radiotherapy bunkers. 
Materials and Methods: The calculation methods used to establish the 
photon and associated neutron dose rates employ the theoretical 
approach from the NCRP Report 151, and the IAEA Safety Report No. 
47, among others. The advantage of including new treatment 
techniques (extra-cranial stereotactic and ablative RT,VMAT, FFF, 
robotic radio-surgery) and newly available constructional materials 
improves the usefulness of the program for any radiotherapy centre. 
The program can evaluate existing bunkers for changes in workload, 
treatment technique or delivery. It contains all variables to enable 
modelling of a new build using concrete,high-density materials and 
layered materials. Calculations using actual workload compared to 
'worst -case' scenarios and the consequences on construction costs 
were evaluated. The contributions of photon, neutron scatter and 
neutron capture gamma rays were investigated with differing maze 
geometries. Special topics such as skyshine and ozone production 
were included too. The program includes all necessary TVLs and other 
intrinsic data, for modelling the spectrum of nominal photon energies 
clinically available, including flattened and flattening-filter-free (FFF) 
beam data. 
Results: The program’s logic and accuracy was successfully validated 
by comparison to literature and using measurements taken at two 
sites with different bunker designs. The program was used to 
calculate potential shielding changes to an existing bunker due to 
increasing the beam energy. The results showed adequate shielding 
except at the maze entrance. The impact of actual workloads versus 
theorised workload was also investigated. There was a 10-20% 
reduction in shielding when the workload theorised in 2003 was 
compared to actual 2012 workload for three bunkers, which could 
reduce the building costs by 10%. 
Conclusions: A comprehensive calculation program for bunker 
shielding was developed to include contemporary and emerging 
treatment methods. Its accuracy and functionality were proven in the 
case studies. It is more functional and manageable than previous 
programs used at the institution.  
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Purpose/Objective: To teach and train a large group of medical 
physicists, dosimetrists and radiation oncologists, working in different 
centres, in proton treatment planning. 
Materials and Methods: A common treatment planning system (TPS) 
for protons is since January 2012 installed and accessible for users in 
seven hospitals. We formed a school to provide the group with a 
common knowledgebase in proton treatment planning. The school 
started with a face-to-face meeting with lectures and workshops and 
continued with biweekly teleconferences. Prior to the teleconference 
the centres were expected to create treatment plans for selected 
patient cases in the common TPS. During the teleconferences, led by 
a chairman, the desktop of the common TPS was shared for everyone 
to view. The teleconferences consisted mainly of discussions about 
the suggested plans, patient fixation, VOI margins, dose distributions 
and plan robustness. We used a check-list to make sure we evaluated 
most relevant issues. After half a year, we changed focus and each 
centre in turn presented a case from their own database. A proton 
plan was created and compared with the actually given photon plan. 
Also here a checklist was used. To prepare for these sessions a number 
of scientific articles regarding related topics were distributed for 
discussions in the group. The TPS vendor also provided a proton 
planning course for this group. A second face-to-face meeting will 
deal with topics like creating common methods for different 
treatment sites, CT calibration, target delineation and study 
protocols. Yet another issue will be to plan future projects for the 
school, e.g. the possibility to invite external lecturers to the school. 
Results: The school has worked out well. All centres have participated 
actively both in planning and discussing, helping each other in gaining 
experience in a field where we are novices, and where the experience 
of this TPS varied within the group. It has been demanding to get the 
radiation oncologists involved. There may be several reasons for this; 
lack of staff, the school has not been properly entered into their work 
schedule or that they are merely used to evaluate plans, rather than 
to discuss the planning process itself, which has been an important 
part of the school. 
Conclusions: The concept is good for any topic were a common base 
line in knowledge is needed, but also as a mean to raise this level. It 
can be used for almost any topic, any number of participants and from 
any computer with a web camera to a conference room with a full 
scale teleconference system. Nevertheless the initial form may need 
revision over time to fit the purpose and the participants. A high 
standard of the teleconference systems is helpful when many people 
are participating. 
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Purpose/Objective: To investigate the association between various 
risk factors, including single nucleotide polymorphisms (SNPs) in 
candidate genes involved in radiation response, and late complications 
to radiotherapy in nasopharyngeal cancer patients. 
Materials and Methods: 155 patients were included in the study. 
Normal tissue fibrosis was scored using RTOG/EORTC grading system. 
11 candidate genes (ATM, XRCC1, XRCC3, XRCC4, XRCC5, PRKDC, 
LIG4, TP53, HDM2, CDKN1A, TGFB1) were selected for their presumed 
influence on radiosensitivity. 45 SNPs (12 primary and 33 neighboring) 
were genotyped by direct genomic DNA sequencing. 
Results: Patients with severe fibrosis (cases, G3-4, n = 48) were 
compared to controls (G0-2, n = 107). Univariate analysis showed 
significant association (P < 0.05) with radiation complications for 6 
SNPs (ATM G/A rs1801516, HDM2 promoter T/G rs2279744 and T/A 
rs1196333, XRCC1 G/A rs25487, XRCC5 T/C rs1051677 and TGFB1 C/T 
rs1800469). In addition, Kaplan-Meier analyses have also invoked 
significant association between genotypes and length of patients' 
follow up after radiotherapy. Multivariate logistic regression has 
further sustained these results suggesting predictive and prognostic 
roles of SNPs. 
Conclusions: Univariate and multivariate analysis suggest that 
radiation toxicity in radiotherapy patients are associated with certain 
SNPs, in genes involved in DNA repair pathways, including HDM2 gene 
promoter studied for the 1st time. In addition, radiosensitive patients 
harbored significantly higher number of risk alleles than controls (P < 
0.001). These results support the use of SNPs as genetic predictive 
markers for clinical radiosensitivity and the use of genotypes 
containing protective alleles as prognostic markers for patients' length 
of follow up after radiotherapy. Funded by KFSHRC grant 2000 031 and 
2040 025.  
   
PO-0898   
Extending RI-MODS: sensitivity of late-responding tissues to 
secondary insult following radiation 
J.P. Williams1, M.K. O'Banion2, J. Olschowka2, E. Lord3, J. Ryan4, J. 
Palis5, L. Calvi6, J.N. Finkelstein7 
1University of Rochester Medical Center, Radiation oncology, 
Rochester NY, USA  
2University of Rochester Medical Center, Neurobiology & Anatomy, 
Rochester NY, USA  
3University of Rochester Medical Center, Immunology, Rochester NY, 
USA  
4University of Rochester Medical Center, Dermatology, Rochester NY, 
USA  
5University of Rochester Medical Center, Hematology/Oncology, 
Rochester NY, USA  
